From investment to IPO: Backing an Egyptian consumer healthcare company
Afsane Jetha, the CEO of Alta Semper, discusses the firm’s investment in Macro Group Pharmaceuticals, highlighting the company’s import substitution strategy and the efforts to prepare it for a stock market listing.